Cheiradone: A vascular endothelial cell growth factor receptor antagonist

BMC Cell Biology

Volumn 9, Issue , 2008, Pages

  Hussain, Sajjad ^a   Slevin, Mark ^a   Mesaik, Mohammad A ^c   Choudhary, Mohammad I ^c   Elosta, Abdul H ^a   Matou, Sabine ^a   Ahmed, Nessar ^a   West, David ^b   Gaffney, John ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEIRADONE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; MATRIGEL; NATURAL PRODUCT; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; ANGIOGENESIS INHIBITOR; COLLAGEN; DITERPENE; LAMININ; PLANT MEDICINAL PRODUCT; PROTEOGLYCAN;

ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; AORTA; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CHICK; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG ISOLATION; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG STRUCTURE; ENDOTHELIUM CELL; EUPHORBIA; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; SKIN CELL; STRUCTURE ANALYSIS; WOUND HEALING; ANGIOGENESIS; ANIMAL; CANCER INVASION; CATTLE; CELL DIFFERENTIATION; CHICK EMBRYO; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; PHYTOTHERAPY; VASCULARIZATION;

BOVINAE; EUPHORBIA;

ANGIOGENESIS INHIBITORS; ANIMALS; CATTLE; CELL DIFFERENTIATION; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; COLLAGEN; DITERPENES; DRUG COMBINATIONS; ENDOTHELIAL CELLS; EPIDERMAL GROWTH FACTOR; EUPHORBIA; FIBROBLAST GROWTH FACTOR 2; HUMANS; LAMININ; NEOPLASM INVASIVENESS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHYTOTHERAPY; PLANT PREPARATIONS; PROTEOGLYCANS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; WOUND HEALING;

EID: 43649089524     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-9-7     Document Type: Article

References (36)

1. Folkman J Angiogenesis: An organizing principle for drug discovery? Nat Rev Drug Discov 2007, 6:273-86 10.1038/nrd2115 17396134
2. Hillen F Griffioen AW Tumour vascularization: Sprouting angiogenesis and beyond Cancer Metastasis Rev 2007, Aug 24 17717633
3. Shima DT Adamis AP Ferrara N Yeo KT Yeo TK Allende R Folkman J D'Amore PA Hypoxic induction of endothelial cell growth factors in retinal cells: Identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen Mol Med 1995, 1:182-193 8529097
4. Li Z Shimada Y Uchida S Maeda M Kawabe A Mori A Itami A Kano M Watanabe G Imamura M TGF-alpha as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma Int J Oncol 2000, 17:453-460 10938383
5. Milkiewicz M Ispanovic E Doyle JL Haas TL Regulators of angiogenesis and strategies for their therapeutic manipulation Int J Biochem Cell iol 2006, 38:333-357 10.1016/j.biocel.2005.10.006
6. Morisada T Kubota Y Urano T Suda T Oike Y Angiopoietins and angiopoietin-like proteins in angiogenesis Endothelium 2006, 13:71-79 10.1080/10623320600697989 16728326
7. Ferrara N Gerber HP LeCouter J The biology of VEGF and its receptors Nat Med 2003, 9:669-676 10.1038/nm0603-669 12778165
8. Takahashi H Shibuya M The vascular endothelial growth factor VEGF/VEGF receptor system and its role under physiological and pathological conditions Clin Sci (Lond) 2005, 109:227-241 16104843
9. McNamara DA Harmey J Wang JH Kay E Walsh TN Bouchier-Hayes DJ Tamoxifen inhibits endothelial cell proliferation and attenuates VEGF-mediated angiogenesis and migration in vivo Eur J Surg Oncol 2001, 27:714-718 10.1053/ejso.2001.1177 11735166
10. Parenti A Bellik L Brogelli L Filippi S Ledda F Endogenous VEGF-A is responsible for mitogenic effects of MCP-1 on vascular smooth muscle cells Am J Physiol Heart Circ Physiol 2004, 286:H1978-1984 10.1152/ ajpheart.00414.2003 14693680
11. Liang D Chang JR Chin AJ Smith A Kelly C Weinberg ES Ge R The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis and hematopoiesis in zebrafish development Mech Dev 2001, 108:29-43 10.1016/S0925-4773(01)00468-3 11578859
12. Nagy JA Dvorak AM Dvorak HF EGF-A(164/165) and PlGF: Roles in angiogenesis and arteriogenesis Trends Cardiovasc Med 2003, HKJ:169-175 10.1016/S1050-1738(03)00056-2
13. Conejo-Garcia JR Benencia F Courreges MC Kang E Mohamed-Hadley A Buckanovich RJ Holtz DO Jenkins A Na H Zhang L Wagner DS Katsaros D Caroll R Coukos G Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of VEGF-A Nat Med 2004, 10:950-958 10.1038/nm1097 15334073
14. Hoeben A Landuyt B Highley MS Wildiers H Van Oosterom AT De Bruijn EA Vascular endothelial growth factor and angiogenesis Pharmacol Rev 2004, 56:549-580 10.1124/pr.56.4.3 15602010
15. Eming SA Krieg T Molecular mechanisms of VEGF-A action during tissue repair J Investig Dermatol Symp Proc 2006, 11:79-86 10.1038/ sj.jidsymp.5650016 17069014
16. Shibuya M Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis Angiogenesis 2006, 9:225-230 10.1007/ s10456-006-9055-8 17109193
17. Zilberberg L Shinkaruk S Lequin O Rousseau B Hagedorn M Costa F Caronzolo D Balke M Canron X Convert O Lain G Gionnet K Goncalves M Bayle M Bello L Chassaing G Deleris G Bikfalvi A Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth factor inhibitor J Biol Chem 2003, 12(278):35564-35573 10.1074/jbc.M304435200
18. Byrne AM Bouchier-Hayes DJ Harmey JH Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF) J Cell Mol Med 2005, 9:777-794 10.1111/j.1582-4934.2005.tb00379.x 16364190
19. Kramer I Lipp HP Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancer J Clin Pharm Ther 2007, 32:1-14 10.1111/j.1365-2710.2007.00800.x 17286784
20. Schneider P Bryan Sledge W George Jr Drug Insight: VEGF as a therapeutic target for breast cancer Nature Clinical Practice Oncology 2007, 4:181-189 10.1038/ncponc0740 17327858
21. Cabebe E Fisher GA Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic ccancer Expert Opin Investig Drugs 2007, 16:467-476 10.1517/13543784.16.4.467 17371195
22. Gridelli C Maione P Del Gaizo F Colantuoni G Guerriero C Ferrara C Nicolella D Comunale D De Vita A Rossi A Sorafenib and sunitinib in the treatment of advanced non-small cell lung cancer Oncologist 2007, 12:191-200 10.1634/theoncologist.12-2-191 17296815
23. Lovkova M Ya GN Buzuk SM Sokolova NI Kliment'eva Chemical Features of Medicinal Plants (Review) Applied Biochemistry and Microbiology 2001, 37:229-237 10.1023/A:1010254131166
24. Abbas M Jassbi AR Zahid M Ali Z Alam N Akhtar F Iqbal Choudhary M Ahmad Uddin Viqar Three new diterpenoids from Euphorbia cheiradenia Helvetica Chimica Acta 2000, 83:2751-2755 10.1002/ 1522-2675(20001004)83:10<2751::AID-HLCA2751>3.0.CO;2-B
25. Schade M Oschkinat H NMR fragments screening: Tackling protein-protein interaction targets Curr Opin Drug Discovery Dev 2005, 8:365-373
26. Eyckerman S Lemmens I Catteeuw D Verhee A Vandekerckhove J Lievens S Tavernier Reverse MAPPIT: Screening for protein-protein interaction modifiers in mammalian cells Nat Methods 2005, 2:427-433 10.1038/ nmeth760 15908921
27. Choi HJ Choi YH Yee SB Im E Jung JH Kim ND Incinin-1 induces cell cycle arrest and apoptosis in SK-MEL-2 human melanoma cell lines Mol Carcinog 2005, 44:162-173 10.1002/mc.20084 16163705
28. Petit GR tan R Cichacz ZA Antineoplastic agent 542. Isolation and structure of sesterstatin from the Indian Ocean sponge Hyrtios erecta J Nat Prod 2005, 68:1253-1255 10.1021/np0402221 16124771
29. Kirsch G Kong GM Wright AD Kaminsky R A new bioactive sesterterpene and antiplasmodial alkaloid from the marine sponge hyrtios cf. erecta J Nat Prod 2000, 63:825-829 10.1021/np990555b 10869210
30. Klagsprun M Folkman J Peptide growth factors and their receptors Springer, NY Sporn MB, Roberts AB 1990, 549-586
31. Dunn I Heese O Blach P growth factors in glioma angiogenesis: FGFs, PDGF, EGF and TGFs J Neuro-Oncol 2000, 50:121-137 10.1023/A:1006436624862
32. Semino CE Kamm RD Lauffenberger DA Autocrine EGF receptor activation mediates endothelial cell migration and vascular morphogenesis by VEGF under interstitial flow Exp Cell Res 2006, 312:289-298 16337626
33. Otrock Z Makarem J Shamseddine A Vascular endothelial growth factor family of ligands and receptors:REview Bllod cells, Molecules and Diseases 2007, 38:258-268 10.1016/j.bcmd.2006.12.003
34. Duraisamy Y Slevin M Smith N Bailey J Zweit J Smith C Ahmed N Gaffney J Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells: Possible relevance to wound healing Angiogenesis 2001, 4:277-288 10.1023/A:1016068917266 12197473
35. Ifat S Tamer L Mink S Noam A Shivani C Dietmar S Dina R Identification of residues important both for primary receptor binding and specificity in fibroblast growth factor-7 J Biol Chem 2003, 275:34881-34886
36. West DC Thompson WD Sellls PG Burbridge MF Angiogenesis assays using the chick chorioallantoic membrane. In Methods in molecular medicine-Angiogenesis: Reviews and Protocols Humana Press Murray JC 2001, 107-130 11300699